nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA9—kidney cancer	0.308	0.526	CbGaD
Dorzolamide—CA2—kidney cancer	0.277	0.473	CbGaD
Dorzolamide—CYP3A4—Everolimus—kidney cancer	0.0276	0.208	CbGbCtD
Dorzolamide—CYP3A4—Temsirolimus—kidney cancer	0.0186	0.141	CbGbCtD
Dorzolamide—CYP2C9—Capecitabine—kidney cancer	0.0176	0.132	CbGbCtD
Dorzolamide—CYP2C9—Paclitaxel—kidney cancer	0.011	0.083	CbGbCtD
Dorzolamide—CYP3A4—Pazopanib—kidney cancer	0.00979	0.0739	CbGbCtD
Dorzolamide—CYP2C9—Sorafenib—kidney cancer	0.00977	0.0737	CbGbCtD
Dorzolamide—CYP3A4—Erlotinib—kidney cancer	0.00698	0.0527	CbGbCtD
Dorzolamide—CA2—collecting duct of renal tubule—kidney cancer	0.00669	0.24	CbGeAlD
Dorzolamide—CYP3A4—Paclitaxel—kidney cancer	0.00639	0.0482	CbGbCtD
Dorzolamide—CYP3A4—Sorafenib—kidney cancer	0.00568	0.0429	CbGbCtD
Dorzolamide—CYP3A4—Vinblastine—kidney cancer	0.00561	0.0423	CbGbCtD
Dorzolamide—CYP3A4—Vincristine—kidney cancer	0.00551	0.0416	CbGbCtD
Dorzolamide—CYP3A4—Sunitinib—kidney cancer	0.0046	0.0347	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—kidney cancer	0.00345	0.026	CbGbCtD
Dorzolamide—Brinzolamide—CA9—kidney cancer	0.00283	0.526	CrCbGaD
Dorzolamide—Brinzolamide—CA2—kidney cancer	0.00254	0.473	CrCbGaD
Dorzolamide—CYP2C9—urine—kidney cancer	0.00202	0.0724	CbGeAlD
Dorzolamide—CA7—renal system—kidney cancer	0.00175	0.0628	CbGeAlD
Dorzolamide—CA7—kidney—kidney cancer	0.00169	0.0607	CbGeAlD
Dorzolamide—CYP3A4—urine—kidney cancer	0.00154	0.0552	CbGeAlD
Dorzolamide—CA14—cardiac atrium—kidney cancer	0.00131	0.0468	CbGeAlD
Dorzolamide—CA12—renal system—kidney cancer	0.00114	0.0408	CbGeAlD
Dorzolamide—CA12—kidney—kidney cancer	0.0011	0.0394	CbGeAlD
Dorzolamide—CA5B—gonad—kidney cancer	0.000916	0.0328	CbGeAlD
Dorzolamide—CA5B—cardiac atrium—kidney cancer	0.000915	0.0328	CbGeAlD
Dorzolamide—CA1—renal system—kidney cancer	0.000902	0.0323	CbGeAlD
Dorzolamide—CA1—kidney—kidney cancer	0.000872	0.0312	CbGeAlD
Dorzolamide—CA4—nephron tubule—kidney cancer	0.000776	0.0278	CbGeAlD
Dorzolamide—CA4—renal system—kidney cancer	0.000705	0.0252	CbGeAlD
Dorzolamide—CA4—kidney—kidney cancer	0.000682	0.0244	CbGeAlD
Dorzolamide—CA4—cortex of kidney—kidney cancer	0.000664	0.0238	CbGeAlD
Dorzolamide—CA2—nephron tubule—kidney cancer	0.000643	0.023	CbGeAlD
Dorzolamide—CA4—cardiac atrium—kidney cancer	0.000631	0.0226	CbGeAlD
Dorzolamide—CA2—renal system—kidney cancer	0.000585	0.0209	CbGeAlD
Dorzolamide—CA2—kidney—kidney cancer	0.000565	0.0202	CbGeAlD
Dorzolamide—CA2—cortex of kidney—kidney cancer	0.00055	0.0197	CbGeAlD
Dorzolamide—CA2—cardiac atrium—kidney cancer	0.000524	0.0187	CbGeAlD
Dorzolamide—CYP3A4—renal system—kidney cancer	0.000377	0.0135	CbGeAlD
Dorzolamide—CYP3A4—kidney—kidney cancer	0.000365	0.0131	CbGeAlD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000112	0.000757	CcSEcCtD
Dorzolamide—Hypersensitivity—Sorafenib—kidney cancer	0.000112	0.000757	CcSEcCtD
Dorzolamide—Insomnia—Vincristine—kidney cancer	0.000112	0.000756	CcSEcCtD
Dorzolamide—Anorexia—Gemcitabine—kidney cancer	0.000112	0.000756	CcSEcCtD
Dorzolamide—Vomiting—Vinblastine—kidney cancer	0.000112	0.000755	CcSEcCtD
Dorzolamide—Dizziness—Erlotinib—kidney cancer	0.000112	0.000755	CcSEcCtD
Dorzolamide—Vomiting—Everolimus—kidney cancer	0.000112	0.000752	CcSEcCtD
Dorzolamide—Paraesthesia—Vincristine—kidney cancer	0.000111	0.000751	CcSEcCtD
Dorzolamide—Rash—Everolimus—kidney cancer	0.000111	0.000746	CcSEcCtD
Dorzolamide—Dermatitis—Everolimus—kidney cancer	0.000111	0.000745	CcSEcCtD
Dorzolamide—Headache—Vinblastine—kidney cancer	0.000111	0.000744	CcSEcCtD
Dorzolamide—Angioedema—Paclitaxel—kidney cancer	0.00011	0.000743	CcSEcCtD
Dorzolamide—Headache—Everolimus—kidney cancer	0.00011	0.000741	CcSEcCtD
Dorzolamide—Hypotension—Gemcitabine—kidney cancer	0.00011	0.000741	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—kidney cancer	0.00011	0.00074	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—kidney cancer	0.00011	0.00074	CcSEcCtD
Dorzolamide—Visual impairment—Capecitabine—kidney cancer	0.00011	0.000739	CcSEcCtD
Dorzolamide—Asthenia—Sorafenib—kidney cancer	0.000109	0.000737	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000109	0.000732	CcSEcCtD
Dorzolamide—Cardiac failure—Doxorubicin—kidney cancer	0.000109	0.000732	CcSEcCtD
Dorzolamide—Vertigo—Paclitaxel—kidney cancer	0.000109	0.000731	CcSEcCtD
Dorzolamide—Syncope—Paclitaxel—kidney cancer	0.000108	0.00073	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000108	0.000729	CcSEcCtD
Dorzolamide—Hypersensitivity—Sunitinib—kidney cancer	0.000108	0.000728	CcSEcCtD
Dorzolamide—Decreased appetite—Vincristine—kidney cancer	0.000108	0.000727	CcSEcCtD
Dorzolamide—Pruritus—Sorafenib—kidney cancer	0.000108	0.000727	CcSEcCtD
Dorzolamide—Vomiting—Erlotinib—kidney cancer	0.000108	0.000726	CcSEcCtD
Dorzolamide—Erythema multiforme—Capecitabine—kidney cancer	0.000108	0.000725	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000107	0.000723	CcSEcCtD
Dorzolamide—Fatigue—Vincristine—kidney cancer	0.000107	0.000721	CcSEcCtD
Dorzolamide—Rash—Erlotinib—kidney cancer	0.000107	0.00072	CcSEcCtD
Dorzolamide—Dermatitis—Erlotinib—kidney cancer	0.000107	0.000719	CcSEcCtD
Dorzolamide—Palpitations—Paclitaxel—kidney cancer	0.000107	0.000719	CcSEcCtD
Dorzolamide—Insomnia—Gemcitabine—kidney cancer	0.000107	0.000717	CcSEcCtD
Dorzolamide—Headache—Erlotinib—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Tinnitus—Capecitabine—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Loss of consciousness—Paclitaxel—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Pain—Vincristine—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—kidney cancer	0.000106	0.000715	CcSEcCtD
Dorzolamide—Paraesthesia—Gemcitabine—kidney cancer	0.000106	0.000712	CcSEcCtD
Dorzolamide—Cough—Paclitaxel—kidney cancer	0.000105	0.00071	CcSEcCtD
Dorzolamide—Asthenia—Sunitinib—kidney cancer	0.000105	0.000709	CcSEcCtD
Dorzolamide—Dyspnoea—Gemcitabine—kidney cancer	0.000105	0.000707	CcSEcCtD
Dorzolamide—Nausea—Vinblastine—kidney cancer	0.000105	0.000706	CcSEcCtD
Dorzolamide—Somnolence—Gemcitabine—kidney cancer	0.000105	0.000705	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—kidney cancer	0.000104	0.000703	CcSEcCtD
Dorzolamide—Nausea—Everolimus—kidney cancer	0.000104	0.000703	CcSEcCtD
Dorzolamide—Diarrhoea—Sorafenib—kidney cancer	0.000104	0.000703	CcSEcCtD
Dorzolamide—Hypertension—Paclitaxel—kidney cancer	0.000104	0.000702	CcSEcCtD
Dorzolamide—Pruritus—Sunitinib—kidney cancer	0.000104	0.000699	CcSEcCtD
Dorzolamide—Chest pain—Paclitaxel—kidney cancer	0.000103	0.000693	CcSEcCtD
Dorzolamide—Arthralgia—Paclitaxel—kidney cancer	0.000103	0.000693	CcSEcCtD
Dorzolamide—Anxiety—Paclitaxel—kidney cancer	0.000103	0.00069	CcSEcCtD
Dorzolamide—Decreased appetite—Gemcitabine—kidney cancer	0.000102	0.000689	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—kidney cancer	0.000102	0.000689	CcSEcCtD
Dorzolamide—Arrhythmia—Capecitabine—kidney cancer	0.000102	0.000685	CcSEcCtD
Dorzolamide—Discomfort—Paclitaxel—kidney cancer	0.000102	0.000684	CcSEcCtD
Dorzolamide—Fatigue—Gemcitabine—kidney cancer	0.000102	0.000684	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Vincristine—kidney cancer	0.000102	0.000684	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—kidney cancer	0.000101	0.00068	CcSEcCtD
Dorzolamide—Dizziness—Sorafenib—kidney cancer	0.000101	0.000679	CcSEcCtD
Dorzolamide—Pain—Gemcitabine—kidney cancer	0.000101	0.000678	CcSEcCtD
Dorzolamide—Nausea—Erlotinib—kidney cancer	0.000101	0.000678	CcSEcCtD
Dorzolamide—Alopecia—Capecitabine—kidney cancer	0.000101	0.000678	CcSEcCtD
Dorzolamide—Dry mouth—Paclitaxel—kidney cancer	0.000101	0.000677	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—kidney cancer	0.000101	0.000677	CcSEcCtD
Dorzolamide—Diarrhoea—Sunitinib—kidney cancer	0.0001	0.000676	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—kidney cancer	9.97e-05	0.000671	CcSEcCtD
Dorzolamide—Confusional state—Paclitaxel—kidney cancer	9.94e-05	0.00067	CcSEcCtD
Dorzolamide—Erythema—Capecitabine—kidney cancer	9.92e-05	0.000668	CcSEcCtD
Dorzolamide—Anaphylactic shock—Paclitaxel—kidney cancer	9.86e-05	0.000664	CcSEcCtD
Dorzolamide—Oedema—Paclitaxel—kidney cancer	9.86e-05	0.000664	CcSEcCtD
Dorzolamide—Abdominal pain—Vincristine—kidney cancer	9.81e-05	0.000661	CcSEcCtD
Dorzolamide—Body temperature increased—Vincristine—kidney cancer	9.81e-05	0.000661	CcSEcCtD
Dorzolamide—Dysgeusia—Capecitabine—kidney cancer	9.71e-05	0.000654	CcSEcCtD
Dorzolamide—Dizziness—Sunitinib—kidney cancer	9.71e-05	0.000654	CcSEcCtD
Dorzolamide—Feeling abnormal—Gemcitabine—kidney cancer	9.71e-05	0.000654	CcSEcCtD
Dorzolamide—Shock—Paclitaxel—kidney cancer	9.7e-05	0.000653	CcSEcCtD
Dorzolamide—Vomiting—Sorafenib—kidney cancer	9.7e-05	0.000653	CcSEcCtD
Dorzolamide—Rash—Sorafenib—kidney cancer	9.62e-05	0.000648	CcSEcCtD
Dorzolamide—Dermatitis—Sorafenib—kidney cancer	9.61e-05	0.000647	CcSEcCtD
Dorzolamide—Back pain—Capecitabine—kidney cancer	9.59e-05	0.000646	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	9.56e-05	0.000644	CcSEcCtD
Dorzolamide—Headache—Sorafenib—kidney cancer	9.56e-05	0.000643	CcSEcCtD
Dorzolamide—Hyperhidrosis—Paclitaxel—kidney cancer	9.53e-05	0.000642	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—kidney cancer	9.51e-05	0.00064	CcSEcCtD
Dorzolamide—Anorexia—Paclitaxel—kidney cancer	9.4e-05	0.000633	CcSEcCtD
Dorzolamide—Vision blurred—Capecitabine—kidney cancer	9.34e-05	0.000629	CcSEcCtD
Dorzolamide—Vomiting—Sunitinib—kidney cancer	9.33e-05	0.000628	CcSEcCtD
Dorzolamide—Body temperature increased—Gemcitabine—kidney cancer	9.31e-05	0.000627	CcSEcCtD
Dorzolamide—Rash—Sunitinib—kidney cancer	9.26e-05	0.000623	CcSEcCtD
Dorzolamide—Dermatitis—Sunitinib—kidney cancer	9.25e-05	0.000623	CcSEcCtD
Dorzolamide—Hypotension—Paclitaxel—kidney cancer	9.21e-05	0.00062	CcSEcCtD
Dorzolamide—Headache—Sunitinib—kidney cancer	9.2e-05	0.000619	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—kidney cancer	9.17e-05	0.000618	CcSEcCtD
Dorzolamide—Hypersensitivity—Vincristine—kidney cancer	9.15e-05	0.000616	CcSEcCtD
Dorzolamide—Nausea—Sorafenib—kidney cancer	9.06e-05	0.00061	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.98e-05	0.000605	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—kidney cancer	8.94e-05	0.000602	CcSEcCtD
Dorzolamide—Insomnia—Paclitaxel—kidney cancer	8.92e-05	0.000601	CcSEcCtD
Dorzolamide—Vertigo—Capecitabine—kidney cancer	8.91e-05	0.0006	CcSEcCtD
Dorzolamide—Asthenia—Vincristine—kidney cancer	8.91e-05	0.0006	CcSEcCtD
Dorzolamide—Syncope—Capecitabine—kidney cancer	8.89e-05	0.000599	CcSEcCtD
Dorzolamide—Paraesthesia—Paclitaxel—kidney cancer	8.85e-05	0.000596	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—kidney cancer	8.84e-05	0.000595	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—kidney cancer	8.82e-05	0.000594	CcSEcCtD
Dorzolamide—Dyspnoea—Paclitaxel—kidney cancer	8.79e-05	0.000592	CcSEcCtD
Dorzolamide—Somnolence—Paclitaxel—kidney cancer	8.77e-05	0.00059	CcSEcCtD
Dorzolamide—Palpitations—Capecitabine—kidney cancer	8.76e-05	0.00059	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—kidney cancer	8.76e-05	0.00059	CcSEcCtD
Dorzolamide—Nausea—Sunitinib—kidney cancer	8.72e-05	0.000587	CcSEcCtD
Dorzolamide—Loss of consciousness—Capecitabine—kidney cancer	8.72e-05	0.000587	CcSEcCtD
Dorzolamide—Dyspepsia—Paclitaxel—kidney cancer	8.68e-05	0.000584	CcSEcCtD
Dorzolamide—Cough—Capecitabine—kidney cancer	8.65e-05	0.000583	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—kidney cancer	8.58e-05	0.000578	CcSEcCtD
Dorzolamide—Decreased appetite—Paclitaxel—kidney cancer	8.57e-05	0.000577	CcSEcCtD
Dorzolamide—Hypertension—Capecitabine—kidney cancer	8.56e-05	0.000576	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—kidney cancer	8.53e-05	0.000574	CcSEcCtD
Dorzolamide—Fatigue—Paclitaxel—kidney cancer	8.5e-05	0.000572	CcSEcCtD
Dorzolamide—Diarrhoea—Vincristine—kidney cancer	8.5e-05	0.000572	CcSEcCtD
Dorzolamide—Asthenia—Gemcitabine—kidney cancer	8.45e-05	0.000569	CcSEcCtD
Dorzolamide—Arthralgia—Capecitabine—kidney cancer	8.44e-05	0.000568	CcSEcCtD
Dorzolamide—Chest pain—Capecitabine—kidney cancer	8.44e-05	0.000568	CcSEcCtD
Dorzolamide—Pain—Paclitaxel—kidney cancer	8.43e-05	0.000568	CcSEcCtD
Dorzolamide—Anxiety—Capecitabine—kidney cancer	8.41e-05	0.000566	CcSEcCtD
Dorzolamide—Discomfort—Capecitabine—kidney cancer	8.34e-05	0.000562	CcSEcCtD
Dorzolamide—Pruritus—Gemcitabine—kidney cancer	8.33e-05	0.000561	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—kidney cancer	8.3e-05	0.000559	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—kidney cancer	8.27e-05	0.000557	CcSEcCtD
Dorzolamide—Dry mouth—Capecitabine—kidney cancer	8.26e-05	0.000556	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—kidney cancer	8.25e-05	0.000556	CcSEcCtD
Dorzolamide—Dizziness—Vincristine—kidney cancer	8.21e-05	0.000553	CcSEcCtD
Dorzolamide—Confusional state—Capecitabine—kidney cancer	8.16e-05	0.000549	CcSEcCtD
Dorzolamide—Feeling abnormal—Paclitaxel—kidney cancer	8.13e-05	0.000547	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	8.11e-05	0.000546	CcSEcCtD
Dorzolamide—Oedema—Capecitabine—kidney cancer	8.09e-05	0.000545	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Paclitaxel—kidney cancer	8.06e-05	0.000543	CcSEcCtD
Dorzolamide—Diarrhoea—Gemcitabine—kidney cancer	8.06e-05	0.000543	CcSEcCtD
Dorzolamide—Shock—Capecitabine—kidney cancer	7.96e-05	0.000536	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—kidney cancer	7.95e-05	0.000535	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—kidney cancer	7.95e-05	0.000535	CcSEcCtD
Dorzolamide—Vomiting—Vincristine—kidney cancer	7.89e-05	0.000532	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—kidney cancer	7.84e-05	0.000528	CcSEcCtD
Dorzolamide—Urticaria—Paclitaxel—kidney cancer	7.83e-05	0.000527	CcSEcCtD
Dorzolamide—Rash—Vincristine—kidney cancer	7.83e-05	0.000527	CcSEcCtD
Dorzolamide—Hyperhidrosis—Capecitabine—kidney cancer	7.82e-05	0.000527	CcSEcCtD
Dorzolamide—Dermatitis—Vincristine—kidney cancer	7.82e-05	0.000527	CcSEcCtD
Dorzolamide—Body temperature increased—Paclitaxel—kidney cancer	7.8e-05	0.000525	CcSEcCtD
Dorzolamide—Abdominal pain—Paclitaxel—kidney cancer	7.8e-05	0.000525	CcSEcCtD
Dorzolamide—Headache—Vincristine—kidney cancer	7.78e-05	0.000524	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—kidney cancer	7.71e-05	0.000519	CcSEcCtD
Dorzolamide—Anorexia—Capecitabine—kidney cancer	7.71e-05	0.000519	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—kidney cancer	7.67e-05	0.000517	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—kidney cancer	7.63e-05	0.000514	CcSEcCtD
Dorzolamide—Hypotension—Capecitabine—kidney cancer	7.56e-05	0.000509	CcSEcCtD
Dorzolamide—Vomiting—Gemcitabine—kidney cancer	7.49e-05	0.000504	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—kidney cancer	7.47e-05	0.000503	CcSEcCtD
Dorzolamide—Rash—Gemcitabine—kidney cancer	7.43e-05	0.0005	CcSEcCtD
Dorzolamide—Dermatitis—Gemcitabine—kidney cancer	7.42e-05	0.0005	CcSEcCtD
Dorzolamide—Headache—Gemcitabine—kidney cancer	7.38e-05	0.000497	CcSEcCtD
Dorzolamide—Nausea—Vincristine—kidney cancer	7.37e-05	0.000497	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.37e-05	0.000496	CcSEcCtD
Dorzolamide—Insomnia—Capecitabine—kidney cancer	7.32e-05	0.000493	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—kidney cancer	7.29e-05	0.000491	CcSEcCtD
Dorzolamide—Paraesthesia—Capecitabine—kidney cancer	7.27e-05	0.000489	CcSEcCtD
Dorzolamide—Hypersensitivity—Paclitaxel—kidney cancer	7.27e-05	0.000489	CcSEcCtD
Dorzolamide—Dyspnoea—Capecitabine—kidney cancer	7.21e-05	0.000486	CcSEcCtD
Dorzolamide—Dyspepsia—Capecitabine—kidney cancer	7.12e-05	0.00048	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—kidney cancer	7.08e-05	0.000476	CcSEcCtD
Dorzolamide—Asthenia—Paclitaxel—kidney cancer	7.08e-05	0.000476	CcSEcCtD
Dorzolamide—Decreased appetite—Capecitabine—kidney cancer	7.03e-05	0.000474	CcSEcCtD
Dorzolamide—Nausea—Gemcitabine—kidney cancer	7e-05	0.000471	CcSEcCtD
Dorzolamide—Fatigue—Capecitabine—kidney cancer	6.98e-05	0.00047	CcSEcCtD
Dorzolamide—Pruritus—Paclitaxel—kidney cancer	6.98e-05	0.00047	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—kidney cancer	6.94e-05	0.000467	CcSEcCtD
Dorzolamide—Pain—Capecitabine—kidney cancer	6.92e-05	0.000466	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—kidney cancer	6.85e-05	0.000461	CcSEcCtD
Dorzolamide—Diarrhoea—Paclitaxel—kidney cancer	6.75e-05	0.000454	CcSEcCtD
Dorzolamide—Feeling abnormal—Capecitabine—kidney cancer	6.67e-05	0.000449	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Capecitabine—kidney cancer	6.62e-05	0.000446	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—kidney cancer	6.56e-05	0.000442	CcSEcCtD
Dorzolamide—Dizziness—Paclitaxel—kidney cancer	6.52e-05	0.000439	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—kidney cancer	6.49e-05	0.000437	CcSEcCtD
Dorzolamide—Urticaria—Capecitabine—kidney cancer	6.43e-05	0.000433	CcSEcCtD
Dorzolamide—Abdominal pain—Capecitabine—kidney cancer	6.4e-05	0.000431	CcSEcCtD
Dorzolamide—Body temperature increased—Capecitabine—kidney cancer	6.4e-05	0.000431	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—kidney cancer	6.39e-05	0.00043	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—kidney cancer	6.27e-05	0.000422	CcSEcCtD
Dorzolamide—Vomiting—Paclitaxel—kidney cancer	6.27e-05	0.000422	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—kidney cancer	6.26e-05	0.000421	CcSEcCtD
Dorzolamide—Rash—Paclitaxel—kidney cancer	6.22e-05	0.000419	CcSEcCtD
Dorzolamide—Dermatitis—Paclitaxel—kidney cancer	6.21e-05	0.000418	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—kidney cancer	6.21e-05	0.000418	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—kidney cancer	6.18e-05	0.000416	CcSEcCtD
Dorzolamide—Headache—Paclitaxel—kidney cancer	6.18e-05	0.000416	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—kidney cancer	6.02e-05	0.000406	CcSEcCtD
Dorzolamide—Hypersensitivity—Capecitabine—kidney cancer	5.96e-05	0.000401	CcSEcCtD
Dorzolamide—Nausea—Paclitaxel—kidney cancer	5.86e-05	0.000394	CcSEcCtD
Dorzolamide—Asthenia—Capecitabine—kidney cancer	5.81e-05	0.000391	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—kidney cancer	5.74e-05	0.000387	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—kidney cancer	5.73e-05	0.000386	CcSEcCtD
Dorzolamide—Pruritus—Capecitabine—kidney cancer	5.73e-05	0.000386	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—kidney cancer	5.65e-05	0.00038	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—kidney cancer	5.62e-05	0.000378	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—kidney cancer	5.58e-05	0.000376	CcSEcCtD
Dorzolamide—Diarrhoea—Capecitabine—kidney cancer	5.54e-05	0.000373	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—kidney cancer	5.52e-05	0.000372	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—kidney cancer	5.44e-05	0.000366	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—kidney cancer	5.44e-05	0.000366	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—kidney cancer	5.42e-05	0.000365	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—kidney cancer	5.38e-05	0.000362	CcSEcCtD
Dorzolamide—Dizziness—Capecitabine—kidney cancer	5.35e-05	0.00036	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—kidney cancer	5.32e-05	0.000358	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—kidney cancer	5.26e-05	0.000354	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—kidney cancer	5.22e-05	0.000351	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—kidney cancer	5.22e-05	0.000351	CcSEcCtD
Dorzolamide—Vomiting—Capecitabine—kidney cancer	5.15e-05	0.000346	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—kidney cancer	5.13e-05	0.000346	CcSEcCtD
Dorzolamide—Rash—Capecitabine—kidney cancer	5.1e-05	0.000344	CcSEcCtD
Dorzolamide—Dermatitis—Capecitabine—kidney cancer	5.1e-05	0.000343	CcSEcCtD
Dorzolamide—Headache—Capecitabine—kidney cancer	5.07e-05	0.000341	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—kidney cancer	5.04e-05	0.00034	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—kidney cancer	4.97e-05	0.000335	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—kidney cancer	4.87e-05	0.000328	CcSEcCtD
Dorzolamide—Nausea—Capecitabine—kidney cancer	4.81e-05	0.000324	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.75e-05	0.00032	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—kidney cancer	4.72e-05	0.000318	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—kidney cancer	4.68e-05	0.000315	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—kidney cancer	4.65e-05	0.000313	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—kidney cancer	4.64e-05	0.000312	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—kidney cancer	4.59e-05	0.000309	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—kidney cancer	4.53e-05	0.000305	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—kidney cancer	4.5e-05	0.000303	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—kidney cancer	4.46e-05	0.0003	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—kidney cancer	4.3e-05	0.000289	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—kidney cancer	4.27e-05	0.000287	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—kidney cancer	4.14e-05	0.000279	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—kidney cancer	4.12e-05	0.000278	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—kidney cancer	4.12e-05	0.000278	CcSEcCtD
Dorzolamide—CA5A—Metabolism—SLC5A5—kidney cancer	3.98e-05	0.000397	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PSMD7—kidney cancer	3.97e-05	0.000396	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PSMD7—kidney cancer	3.97e-05	0.000396	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—RELA—kidney cancer	3.96e-05	0.000394	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—SLC2A1—kidney cancer	3.95e-05	0.000393	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MTOR—kidney cancer	3.88e-05	0.000387	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	3.85e-05	0.000384	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—SLC2A1—kidney cancer	3.85e-05	0.000383	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—SLC2A1—kidney cancer	3.85e-05	0.000383	CbGpPWpGaD
Dorzolamide—Hypersensitivity—Doxorubicin—kidney cancer	3.84e-05	0.000259	CcSEcCtD
Dorzolamide—CA12—Metabolism—SCARB1—kidney cancer	3.79e-05	0.000377	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CRABP1—kidney cancer	3.76e-05	0.000375	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—BCHE—kidney cancer	3.76e-05	0.000375	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—BCHE—kidney cancer	3.76e-05	0.000375	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS1—kidney cancer	3.75e-05	0.000374	CbGpPWpGaD
Dorzolamide—Asthenia—Doxorubicin—kidney cancer	3.74e-05	0.000252	CcSEcCtD
Dorzolamide—CA5B—Metabolism—SLC5A5—kidney cancer	3.72e-05	0.00037	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—SLC5A5—kidney cancer	3.72e-05	0.00037	CbGpPWpGaD
Dorzolamide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	3.71e-05	0.00037	CbGpPWpGaD
Dorzolamide—Pruritus—Doxorubicin—kidney cancer	3.69e-05	0.000249	CcSEcCtD
Dorzolamide—CA12—Metabolism—PSMD7—kidney cancer	3.68e-05	0.000366	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	3.64e-05	0.000363	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CRABP1—kidney cancer	3.61e-05	0.00036	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	3.61e-05	0.000359	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—SLC2A1—kidney cancer	3.59e-05	0.000358	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—SLC2A1—kidney cancer	3.59e-05	0.000358	CbGpPWpGaD
Dorzolamide—Diarrhoea—Doxorubicin—kidney cancer	3.57e-05	0.00024	CcSEcCtD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.56e-05	0.000355	CbGpPWpGaD
Dorzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.51e-05	0.00035	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ITPR2—kidney cancer	3.5e-05	0.000349	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—BCHE—kidney cancer	3.49e-05	0.000347	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—JUN—kidney cancer	3.47e-05	0.000345	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CRABP1—kidney cancer	3.46e-05	0.000345	CbGpPWpGaD
Dorzolamide—Dizziness—Doxorubicin—kidney cancer	3.45e-05	0.000232	CcSEcCtD
Dorzolamide—CA12—Metabolism—SLC5A5—kidney cancer	3.44e-05	0.000343	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ITPR2—kidney cancer	3.35e-05	0.000334	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—SLC2A1—kidney cancer	3.33e-05	0.000331	CbGpPWpGaD
Dorzolamide—Vomiting—Doxorubicin—kidney cancer	3.32e-05	0.000223	CcSEcCtD
Dorzolamide—CA14—Metabolism—GSTP1—kidney cancer	3.29e-05	0.000328	CbGpPWpGaD
Dorzolamide—Rash—Doxorubicin—kidney cancer	3.29e-05	0.000221	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—kidney cancer	3.29e-05	0.000221	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—kidney cancer	3.27e-05	0.00022	CcSEcCtD
Dorzolamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.26e-05	0.000325	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ITPR2—kidney cancer	3.22e-05	0.000321	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTP1—kidney cancer	3.21e-05	0.00032	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTP1—kidney cancer	3.21e-05	0.00032	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ACHE—kidney cancer	3.19e-05	0.000318	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTT1—kidney cancer	3.19e-05	0.000318	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.18e-05	0.000317	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ABCB1—kidney cancer	3.12e-05	0.00031	CbGpPWpGaD
Dorzolamide—Nausea—Doxorubicin—kidney cancer	3.1e-05	0.000209	CcSEcCtD
Dorzolamide—CA2—Metabolism—ACHE—kidney cancer	3.06e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTT1—kidney cancer	3.06e-05	0.000305	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CRABP1—kidney cancer	3.04e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ABCB1—kidney cancer	3.04e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ABCB1—kidney cancer	3.04e-05	0.000303	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.03e-05	0.000302	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—GSTM1—kidney cancer	3.02e-05	0.000301	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SCARB1—kidney cancer	3.02e-05	0.000301	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTP1—kidney cancer	2.99e-05	0.000298	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTP1—kidney cancer	2.99e-05	0.000298	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS1—kidney cancer	2.99e-05	0.000298	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—GSTM1—kidney cancer	2.95e-05	0.000294	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—GSTM1—kidney cancer	2.95e-05	0.000294	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ACHE—kidney cancer	2.93e-05	0.000292	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTT1—kidney cancer	2.93e-05	0.000292	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PSMD7—kidney cancer	2.93e-05	0.000292	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SCARB1—kidney cancer	2.9e-05	0.000289	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.89e-05	0.000288	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS1—kidney cancer	2.87e-05	0.000286	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—CYP1A1—kidney cancer	2.87e-05	0.000286	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MAPK3—kidney cancer	2.86e-05	0.000285	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ABCB1—kidney cancer	2.83e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ABCB1—kidney cancer	2.83e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ITPR2—kidney cancer	2.83e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PSMD7—kidney cancer	2.81e-05	0.00028	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—CYP1A1—kidney cancer	2.79e-05	0.000278	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—CYP1A1—kidney cancer	2.79e-05	0.000278	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—BCHE—kidney cancer	2.78e-05	0.000277	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SCARB1—kidney cancer	2.78e-05	0.000277	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTP1—kidney cancer	2.77e-05	0.000276	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—GSTM1—kidney cancer	2.75e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—GSTM1—kidney cancer	2.75e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS1—kidney cancer	2.75e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SLC5A5—kidney cancer	2.75e-05	0.000274	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.72e-05	0.000272	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PSMD7—kidney cancer	2.7e-05	0.000269	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.67e-05	0.000266	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—BCHE—kidney cancer	2.67e-05	0.000266	CbGpPWpGaD
Dorzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.65e-05	0.000264	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—SLC2A1—kidney cancer	2.65e-05	0.000264	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SLC5A5—kidney cancer	2.63e-05	0.000262	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.63e-05	0.000262	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ABCB1—kidney cancer	2.63e-05	0.000262	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—CYP1A1—kidney cancer	2.61e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—CYP1A1—kidney cancer	2.61e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ACHE—kidney cancer	2.58e-05	0.000257	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTT1—kidney cancer	2.58e-05	0.000257	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—BCHE—kidney cancer	2.56e-05	0.000255	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—GSTM1—kidney cancer	2.55e-05	0.000254	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—SLC2A1—kidney cancer	2.54e-05	0.000253	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.54e-05	0.000253	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SLC5A5—kidney cancer	2.52e-05	0.000252	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.45e-05	0.000244	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SCARB1—kidney cancer	2.44e-05	0.000243	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—SLC2A1—kidney cancer	2.44e-05	0.000243	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.42e-05	0.000241	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS1—kidney cancer	2.42e-05	0.000241	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CYP1A1—kidney cancer	2.42e-05	0.000241	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.38e-05	0.000237	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PSMD7—kidney cancer	2.37e-05	0.000236	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.32e-05	0.000232	CbGpPWpGaD
Dorzolamide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.29e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—TP53—kidney cancer	2.29e-05	0.000228	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—BCHE—kidney cancer	2.25e-05	0.000224	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SLC5A5—kidney cancer	2.22e-05	0.000221	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTP1—kidney cancer	2.21e-05	0.00022	CbGpPWpGaD
Dorzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.15e-05	0.000214	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—SLC2A1—kidney cancer	2.14e-05	0.000214	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—POMC—kidney cancer	2.14e-05	0.000213	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTP1—kidney cancer	2.12e-05	0.000211	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ABCB1—kidney cancer	2.09e-05	0.000209	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—POMC—kidney cancer	2.08e-05	0.000208	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—POMC—kidney cancer	2.08e-05	0.000208	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACY1—kidney cancer	2.04e-05	0.000204	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTP1—kidney cancer	2.03e-05	0.000203	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—kidney cancer	2.03e-05	0.000203	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ABCB1—kidney cancer	2.01e-05	0.0002	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTM1—kidney cancer	1.95e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—POMC—kidney cancer	1.94e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—POMC—kidney cancer	1.94e-05	0.000194	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CYP1A1—kidney cancer	1.93e-05	0.000192	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ABCB1—kidney cancer	1.92e-05	0.000192	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—kidney cancer	1.87e-05	0.000186	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CYP1A1—kidney cancer	1.85e-05	0.000184	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—POMC—kidney cancer	1.8e-05	0.00018	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTP1—kidney cancer	1.79e-05	0.000178	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CYP1A1—kidney cancer	1.77e-05	0.000176	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.76e-05	0.000175	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.74e-05	0.000174	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PDHB—kidney cancer	1.74e-05	0.000173	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.74e-05	0.000173	CbGpPWpGaD
Dorzolamide—CYP2C9—Biological oxidations—POMC—kidney cancer	1.73e-05	0.000173	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—kidney cancer	1.7e-05	0.00017	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCB1—kidney cancer	1.69e-05	0.000169	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000166	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—kidney cancer	1.66e-05	0.000166	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—kidney cancer	1.64e-05	0.000164	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CCBL1—kidney cancer	1.63e-05	0.000163	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.62e-05	0.000161	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.59e-05	0.000159	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CYP1A1—kidney cancer	1.56e-05	0.000155	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—kidney cancer	1.55e-05	0.000155	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—kidney cancer	1.55e-05	0.000155	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.53e-05	0.000153	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.51e-05	0.000151	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTEN—kidney cancer	1.49e-05	0.000148	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.48e-05	0.000147	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTEN—kidney cancer	1.45e-05	0.000144	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTEN—kidney cancer	1.45e-05	0.000144	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—kidney cancer	1.44e-05	0.000143	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—POMC—kidney cancer	1.44e-05	0.000143	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPAT—kidney cancer	1.42e-05	0.000141	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.42e-05	0.000141	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.4e-05	0.000139	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.38e-05	0.000138	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—POMC—kidney cancer	1.38e-05	0.000137	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTEN—kidney cancer	1.35e-05	0.000135	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTEN—kidney cancer	1.35e-05	0.000135	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.35e-05	0.000134	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—POMC—kidney cancer	1.32e-05	0.000132	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FH—kidney cancer	1.32e-05	0.000131	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APRT—kidney cancer	1.32e-05	0.000131	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.29e-05	0.000128	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTEN—kidney cancer	1.25e-05	0.000125	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPC3—kidney cancer	1.24e-05	0.000123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA2—kidney cancer	1.2e-05	0.00012	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALAD—kidney cancer	1.17e-05	0.000117	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—POMC—kidney cancer	1.16e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.15e-05	0.000114	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.15e-05	0.000114	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—kidney cancer	1.15e-05	0.000114	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.14e-05	0.000114	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.12e-05	0.000112	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—kidney cancer	1.1e-05	0.000109	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.08e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.07e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PGK1—kidney cancer	1.07e-05	0.000107	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—kidney cancer	1.05e-05	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDHB—kidney cancer	1.05e-05	0.000105	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—kidney cancer	1.05e-05	0.000105	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—kidney cancer	1.02e-05	0.000102	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—kidney cancer	1.02e-05	0.000102	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTEN—kidney cancer	9.99e-06	9.96e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTEN—kidney cancer	9.58e-06	9.55e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—kidney cancer	9.54e-06	9.51e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—kidney cancer	9.54e-06	9.51e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPAT—kidney cancer	9.35e-06	9.31e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.35e-06	9.31e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—kidney cancer	9.26e-06	9.23e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTEN—kidney cancer	9.19e-06	9.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CA9—kidney cancer	9.13e-06	9.1e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.92e-06	8.89e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—kidney cancer	8.84e-06	8.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APRT—kidney cancer	8.69e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FH—kidney cancer	8.69e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPC3—kidney cancer	8.17e-06	8.14e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTEN—kidney cancer	8.08e-06	8.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA2—kidney cancer	7.95e-06	7.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CRABP1—kidney cancer	7.76e-06	7.74e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALAD—kidney cancer	7.74e-06	7.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.56e-06	7.53e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.39e-06	7.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ITPR2—kidney cancer	7.22e-06	7.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PGK1—kidney cancer	7.08e-06	7.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.08e-06	7.06e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—kidney cancer	7.05e-06	7.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDHB—kidney cancer	6.95e-06	6.92e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—kidney cancer	6.76e-06	6.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.65e-06	6.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—kidney cancer	6.58e-06	6.56e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACHE—kidney cancer	6.58e-06	6.56e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—kidney cancer	6.48e-06	6.46e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SCARB1—kidney cancer	6.23e-06	6.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS1—kidney cancer	6.17e-06	6.15e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PSMD7—kidney cancer	6.05e-06	6.03e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CA9—kidney cancer	6.02e-06	6e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BCHE—kidney cancer	5.73e-06	5.71e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—kidney cancer	5.7e-06	5.68e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.66e-06	5.64e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.47e-06	5.45e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.31e-06	5.29e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CRABP1—kidney cancer	5.12e-06	5.1e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ITPR2—kidney cancer	4.76e-06	4.74e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.63e-06	4.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—kidney cancer	4.56e-06	4.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACHE—kidney cancer	4.34e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—kidney cancer	4.34e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCB1—kidney cancer	4.32e-06	4.3e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—kidney cancer	4.19e-06	4.18e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SCARB1—kidney cancer	4.11e-06	4.09e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS1—kidney cancer	4.07e-06	4.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSMD7—kidney cancer	3.99e-06	3.98e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.97e-06	3.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BCHE—kidney cancer	3.78e-06	3.77e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.74e-06	3.72e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.61e-06	3.59e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.27e-06	3.25e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.01e-06	3e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—POMC—kidney cancer	2.96e-06	2.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCB1—kidney cancer	2.85e-06	2.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.77e-06	2.76e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.62e-06	2.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—kidney cancer	2.36e-06	2.36e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTEN—kidney cancer	2.06e-06	2.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—POMC—kidney cancer	1.95e-06	1.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.56e-06	1.55e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.45e-06	1.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.36e-06	1.35e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.59e-07	9.56e-06	CbGpPWpGaD
